A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients
Status:
Withdrawn
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, single-blinded, randomized, case-control study. The
study is conducted by a single investigator at an orthopedic surgery institute, with a
minimum 6 week post operative follow-up period of TKA patients who receive Exparel compared
with the surgeon's standard method (detailed below) for pain management intraoperatively.